Healthcare

Ideally I'd like to buy a negative response to Janet Yellen tomorrow.
You can bet that at the next hint of an unfair price hike, politicians will be waiting to pounce.
You can bet that at the next hint of an unfair price hike, politicians will be waiting to pounce.
Pfizer's second acquisition this week could add risk. Some retailers attract portfolio managers.
Consider that the $70 line of support.
I do think we could rebound back into the $61-$62 range.
Redhill has some promising drugs in its pipeline, and is well funded.
Its long-term reputation appears to be supporting the shares far more than they deserve.
Some small caps I own are on the move of late, and are still attractive.
Valeant soars as short thesis gets debunked, and Twitter could be close to teaming up with Apple.

Columnist Conversations

The dollar index ended up holding support nicely into both the time and price parameters discussed last ...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.